Selected research
Industry Growth & Trends
Global Gliquidone Tablets Industry Growth and Trends Forecast to 2032
Market perspective
The global Gliquidone Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Gliquidone Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Gliquidone Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gliquidone Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Gliquidone Tablets include TIPR Pharmaceutical, Boehringer Ingelheim, Chengdu Hengrui Pharmaceutical, China Resources Double-crane Pharmaceutical, Jilin Jian Yisheng Pharmaceutical and Shenzhen Zhonglian Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Gliquidone Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Gliquidone Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gliquidone Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gliquidone Tablets.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Gliquidone Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Gliquidone Tablets Market by Company
TIPR Pharmaceutical
Boehringer Ingelheim
Chengdu Hengrui Pharmaceutical
China Resources Double-crane Pharmaceutical
Jilin Jian Yisheng Pharmaceutical
Shenzhen Zhonglian Pharmaceutical
Gliquidone Tablets Segment by Type
Original Drug
Generic Drug
Gliquidone Tablets Segment by Application
Hospital and Clinic
Pharmacy
Gliquidone Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gliquidone Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gliquidone Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gliquidone Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gliquidone Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Gliquidone Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Original Drug
- Generic Drug
Applications
- Hospital and Clinic
- Pharmacy
Companies covered
- TIPR Pharmaceutical
- Boehringer Ingelheim
- Chengdu Hengrui Pharmaceutical
- China Resources Double-crane Pharmaceutical
- Jilin Jian Yisheng Pharmaceutical
- Shenzhen Zhonglian Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Gliquidone Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Gliquidone Tablets Sales Estimates and Forecasts (2021-2032)
- 1.3 Gliquidone Tablets Market by Type
- 1.3.1 Original Drug
- 1.3.2 Generic Drug
- 1.4 Global Gliquidone Tablets Market Size by Type
- 1.4.1 Global Gliquidone Tablets Market Size Overview by Type (2021-2032)
- 1.4.2 Global Gliquidone Tablets Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Gliquidone Tablets Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Gliquidone Tablets Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Gliquidone Tablets Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Gliquidone Tablets Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Gliquidone Tablets Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Gliquidone Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Gliquidone Tablets Industry Trends
- 2.2 Gliquidone Tablets Industry Drivers
- 2.3 Gliquidone Tablets Industry Opportunities and Challenges
- 2.4 Gliquidone Tablets Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Gliquidone Tablets Revenue (2021-2026)
- 3.2 Global Top Players by Gliquidone Tablets Sales (2021-2026)
- 3.3 Global Top Players by Gliquidone Tablets Price (2021-2026)
- 3.4 Global Gliquidone Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Gliquidone Tablets Major Company Production Sites & Headquarters
- 3.6 Global Gliquidone Tablets Company, Product Type & Application
- 3.7 Global Gliquidone Tablets Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Gliquidone Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Gliquidone Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Gliquidone Tablets Tier 1, Tier 2, and Tier 3
4 Gliquidone Tablets Regional Status and Outlook
- 4.1 Global Gliquidone Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Gliquidone Tablets Historic Market Size by Region
- 4.2.1 Global Gliquidone Tablets Sales in Volume by Region (2021-2026)
- 4.2.2 Global Gliquidone Tablets Sales in Value by Region (2021-2026)
- 4.2.3 Global Gliquidone Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Gliquidone Tablets Forecasted Market Size by Region
- 4.3.1 Global Gliquidone Tablets Sales in Volume by Region (2027-2032)
- 4.3.2 Global Gliquidone Tablets Sales in Value by Region (2027-2032)
- 4.3.3 Global Gliquidone Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Gliquidone Tablets by Application
- 5.1 Gliquidone Tablets Market by Application
- 5.1.1 Hospital and Clinic
- 5.1.2 Pharmacy
- 5.2 Global Gliquidone Tablets Market Size by Application
- 5.2.1 Global Gliquidone Tablets Market Size Overview by Application (2021-2032)
- 5.2.2 Global Gliquidone Tablets Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Gliquidone Tablets Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Gliquidone Tablets Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Gliquidone Tablets Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Gliquidone Tablets Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Gliquidone Tablets Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Gliquidone Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 TIPR Pharmaceutical
- 6.1.1 TIPR Pharmaceutical Company Information
- 6.1.2 TIPR Pharmaceutical Business Overview
- 6.1.3 TIPR Pharmaceutical Gliquidone Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 TIPR Pharmaceutical Gliquidone Tablets Product Portfolio
- 6.1.5 TIPR Pharmaceutical Recent Developments
- 6.2 Boehringer Ingelheim
- 6.2.1 Boehringer Ingelheim Company Information
- 6.2.2 Boehringer Ingelheim Business Overview
- 6.2.3 Boehringer Ingelheim Gliquidone Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Boehringer Ingelheim Gliquidone Tablets Product Portfolio
- 6.2.5 Boehringer Ingelheim Recent Developments
- 6.3 Chengdu Hengrui Pharmaceutical
- 6.3.1 Chengdu Hengrui Pharmaceutical Company Information
- 6.3.2 Chengdu Hengrui Pharmaceutical Business Overview
- 6.3.3 Chengdu Hengrui Pharmaceutical Gliquidone Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Chengdu Hengrui Pharmaceutical Gliquidone Tablets Product Portfolio
- 6.3.5 Chengdu Hengrui Pharmaceutical Recent Developments
- 6.4 China Resources Double-crane Pharmaceutical
- 6.4.1 China Resources Double-crane Pharmaceutical Company Information
- 6.4.2 China Resources Double-crane Pharmaceutical Business Overview
- 6.4.3 China Resources Double-crane Pharmaceutical Gliquidone Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 China Resources Double-crane Pharmaceutical Gliquidone Tablets Product Portfolio
- 6.4.5 China Resources Double-crane Pharmaceutical Recent Developments
- 6.5 Jilin Jian Yisheng Pharmaceutical
- 6.5.1 Jilin Jian Yisheng Pharmaceutical Company Information
- 6.5.2 Jilin Jian Yisheng Pharmaceutical Business Overview
- 6.5.3 Jilin Jian Yisheng Pharmaceutical Gliquidone Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Jilin Jian Yisheng Pharmaceutical Gliquidone Tablets Product Portfolio
- 6.5.5 Jilin Jian Yisheng Pharmaceutical Recent Developments
- 6.6 Shenzhen Zhonglian Pharmaceutical
- 6.6.1 Shenzhen Zhonglian Pharmaceutical Company Information
- 6.6.2 Shenzhen Zhonglian Pharmaceutical Business Overview
- 6.6.3 Shenzhen Zhonglian Pharmaceutical Gliquidone Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Shenzhen Zhonglian Pharmaceutical Gliquidone Tablets Product Portfolio
- 6.6.5 Shenzhen Zhonglian Pharmaceutical Recent Developments
7 North America by Country
- 7.1 North America Gliquidone Tablets Sales by Country
- 7.1.1 North America Gliquidone Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Gliquidone Tablets Sales by Country (2021-2026)
- 7.1.3 North America Gliquidone Tablets Sales Forecast by Country (2027-2032)
- 7.2 North America Gliquidone Tablets Market Size by Country
- 7.2.1 North America Gliquidone Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Gliquidone Tablets Market Size by Country (2021-2026)
- 7.2.3 North America Gliquidone Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Gliquidone Tablets Sales by Country
- 8.1.1 Europe Gliquidone Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Gliquidone Tablets Sales by Country (2021-2026)
- 8.1.3 Europe Gliquidone Tablets Sales Forecast by Country (2027-2032)
- 8.2 Europe Gliquidone Tablets Market Size by Country
- 8.2.1 Europe Gliquidone Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Gliquidone Tablets Market Size by Country (2021-2026)
- 8.2.3 Europe Gliquidone Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Gliquidone Tablets Sales by Country
- 9.1.1 Asia-Pacific Gliquidone Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Gliquidone Tablets Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Gliquidone Tablets Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Gliquidone Tablets Market Size by Country
- 9.2.1 Asia-Pacific Gliquidone Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Gliquidone Tablets Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Gliquidone Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Gliquidone Tablets Sales by Country
- 10.1.1 South America Gliquidone Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Gliquidone Tablets Sales by Country (2021-2026)
- 10.1.3 South America Gliquidone Tablets Sales Forecast by Country (2027-2032)
- 10.2 South America Gliquidone Tablets Market Size by Country
- 10.2.1 South America Gliquidone Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Gliquidone Tablets Market Size by Country (2021-2026)
- 10.2.3 South America Gliquidone Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Gliquidone Tablets Sales by Country
- 11.1.1 Middle East and Africa Gliquidone Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Gliquidone Tablets Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Gliquidone Tablets Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Gliquidone Tablets Market Size by Country
- 11.2.1 Middle East and Africa Gliquidone Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Gliquidone Tablets Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Gliquidone Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Gliquidone Tablets Value Chain Analysis
- 12.1.1 Gliquidone Tablets Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Gliquidone Tablets Production Mode & Process
- 12.2 Gliquidone Tablets Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Gliquidone Tablets Distributors
- 12.2.3 Gliquidone Tablets Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst